ECL vs VXRT · P/E 35, rev $4.01B vs rev $28.7M
Ecolab Inc (ECL) versus Vaxart Inc (VXRT) — a side-by-side from cached financials, not a winner call.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Vaxart Inc (VXRT) is a biotechnology company listed on US.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Latest reported VXRT revenue for 2024-12-31 was $28.7M. Net income was -$66.9M. Revenue was up 288.9% from 2023-12-31 to 2024-12-31. VXRT currently screens at market cap $73.0M.
ECL currently screens at market cap $72.05B and trailing P/E 34.6. VXRT currently screens at market cap $73.0M.
Not investment advice. Open the ECL and VXRT stock pages for the full models.
Not investment advice.